[Testosterone and the prostate]
- PMID: 15368045
- DOI: 10.1007/s00120-004-0654-y
[Testosterone and the prostate]
Abstract
Testosterone has a distinct role in benign and malignant diseases of the prostate. Therefore, knowledge about the physiological interactions between testosterone and the prostate and the special circumstances under testosterone substitution are of great impact for urologists.PSA value and prostate volume do not show significant changes under testosterone substitution therapy. Even if there are no long-term studies in men under substitution due to decreased testosterone, the therapy seems to be safe under regular control of the prostate with PSA and sonography, and the risk for prostate carcinoma is not increased. In hypogonadal men with high-grade PIN under testosterone substitution, 1 in 20 cases with suspicious rectal examination exhibited a carcinoma; the PSA values did not show a difference between men with or without PIN.Nevertheless, it remains unclear whether men after successful radical prostatectomy should receive testosterone substitution.
Similar articles
-
[Testosterone substitution in aging males. Which questions are answered?].Urologe A. 2004 Sep;43(9):1097-100. doi: 10.1007/s00120-004-0648-9. Urologe A. 2004. PMID: 15368046 Review. German.
-
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413
-
[Testosterone substitution with special regard to prostate cancer].Urologe A. 2008 Dec;47(12):1588-91. doi: 10.1007/s00120-008-1798-y. Urologe A. 2008. PMID: 18931991 German.
-
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.BJU Int. 2017 Feb;119(2):216-224. doi: 10.1111/bju.13578. Epub 2016 Aug 14. BJU Int. 2017. PMID: 27409523
-
Testosterone replacement therapy and prostate cancer: a word of caution.Curr Urol Rep. 2007 May;8(3):185-9. doi: 10.1007/s11934-007-0004-x. Curr Urol Rep. 2007. PMID: 17459266 Review.
Cited by
-
[Testosterone replacement therapy for prostate cancer].Urologe A. 2010 Jan;49(1):20-5. doi: 10.1007/s00120-009-2194-y. Urologe A. 2010. PMID: 20057988 German.
-
[Testosterone substitution therapy in prostate cancer].Urologe A. 2011 Aug;50(8):977-84. doi: 10.1007/s00120-011-2610-y. Urologe A. 2011. PMID: 21811932 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous